ArticleThoracic cancer2023

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Hiromi Tomono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.